Literature DB >> 14641086

Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid.

A R Smith1, T M Hagen.   

Abstract

Aging is the single largest risk factor for cardiovascular diseases, which in turn are the leading cause of death of individuals over the age of 65 years. In part, this risk is due to a profound loss of vasomotor function of the major conduit arteries, primarily because of lower levels of endothelial-derived nitric oxide. The mechanisms involved in vascular dysfunction are not entirely understood, but age-related alterations in eNOS (endothelial nitric oxide synthase) activity appear to be a likely source of the aging lesion. However, age-related changes in cell signalling that ultimately affect eNOS phosphorylation and its activity have not been explored. Results in our laboratory indicate that levels of eNOS phosphorylation in aortas from aged F344xBN rats (28-30 months old) are almost 50% lower than in aortas from young animals (3 months old). Lower eNOS phosphorylation is directly attributable to loss of constitutive Akt/protein kinase B activity. The decline in eNOS phosphorylation can be partially restored by treating old rats with (R)-alpha-lipoic acid. These results thus suggest that age-related changes in eNOS phosphorylation may be a significant factor in the overall loss of vasomotor function in the elderly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641086     DOI: 10.1042/bst0311447

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  28 in total

1.  Effect of age and exercise training on protein:protein interactions among eNOS and its regulatory proteins in rat aortas.

Authors:  Meredith J Luttrell; John W Seawright; Emily Wilson; Christopher R Woodman
Journal:  Eur J Appl Physiol       Date:  2013-08-31       Impact factor: 3.078

2.  Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by alpha-lipoic acid through PI3 kinase, PTEN, and PP2A.

Authors:  Kate Petersen Shay; Tory M Hagen
Journal:  Biogerontology       Date:  2008-10-18       Impact factor: 4.277

Review 3.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

Review 4.  Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors:  Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

Review 5.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 6.  Mitochondria and endothelial function.

Authors:  Matthew A Kluge; Jessica L Fetterman; Joseph A Vita
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

Review 7.  Kidney aging--inevitable or preventable?

Authors:  Devasmita Choudhury; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

8.  Nitric oxide effects on the function of aged cells ex vivo and in vivo.

Authors:  May J Reed; Daniel Eyman; Nathan Karres
Journal:  In Vivo       Date:  2008 Nov-Dec       Impact factor: 2.155

9.  Lipoic acid significantly restores, in rats, the age-related decline in vasomotion.

Authors:  A R Smith; F Visioli; B Frei; T M Hagen
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

10.  Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats.

Authors:  Frederic Pinaud; Arnaud Bocquet; Odile Dumont; Kevin Retailleau; Christophe Baufreton; Ramaroson Andriantsitohaina; Laurent Loufrani; Daniel Henrion
Journal:  Hypertension       Date:  2007-05-07       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.